title: Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior.
abstract: Normal and malignant cells release a variety of different vesicles into their extracellular environment. The most prominent vesicles are the microvesicles (MVs, 100-1000 nm in diameter), which are shed of the plasma membrane, and the exosomes (70-120 nm in diameter), derivates of the endosomal system. MVs have been associated with intercellular communication processes and transport numerous proteins, lipids and RNAs. As essential component of immune-escape mechanisms tumor-derived MVs suppress immune responses. Additionally, tumor-derived MVs have been found to promote metastasis, tumor-stroma interactions and angiogenesis. Since members of the carcinoembryonic antigen related cell adhesion molecule (CEACAM)-family have been associated with similar processes, we studied the distribution and function of CEACAMs in MV fractions of different human epithelial tumor cells and of human and murine endothelial cells. Here we demonstrate that in association to their cell surface phenotype, MVs released from different human epithelial tumor cells contain CEACAM1, CEACAM5 and CEACAM6, while human and murine endothelial cells were positive for CEACAM1 only. Furthermore, MVs derived from CEACAM1 transfected CHO cells carried CEACAM1. In terms of their secretion kinetics, we show that MVs are permanently released in low doses, which are extensively increased upon cellular starvation stress. Although CEACAM1 did not transmit signals into MVs it served as ligand for CEACAM expressing cell types. We gained evidence that CEACAM1-positive MVs significantly increase the CD3 and CD3/CD28-induced T-cell proliferation. All together, our data demonstrate that MV-bound forms of CEACAMs play important roles in intercellular communication processes, which can modulate immune response, tumor progression, metastasis and angiogenesis.
authors.affiliation: Institute of Anatomy, University Hospital Essen, Essen, Germany.
authors.forename: Harrison T
authors.initials: HT
authors.lastname: Muturi
authors.forename: Janine D
authors.initials: JD
authors.lastname: Dreesen
authors.forename: Elena
authors.initials: E
authors.lastname: Nilewski
authors.forename: Holger
authors.initials: H
authors.lastname: Jastrow
authors.forename: Bernd
authors.initials: B
authors.lastname: Giebel
authors.forename: Suleyman
authors.initials: S
authors.lastname: Ergun
authors.forename: Bernhard B
authors.initials: BB
authors.lastname: Singer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D015703:Antigens, CD / Q000378:metabolism*; D018106:CD28 Antigens / Q000378:metabolism; D017252:CD3 Complex / Q000378:metabolism; D016466:CHO Cells; D015815:Cell Adhesion Molecules / Q000378:metabolism*; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism; D049109:Cell Proliferation; D006224:Cricetinae; D003412:Cricetulus; D011992:Endosomes / Q000378:metabolism; D042783:Endothelial Cells / Q000166:cytology*; D006801:Humans; D051379:Mice; D008833:Microcirculation; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic; D010766:Phosphorylation; D013601:T-Lymphocytes / Q000166:cytology*; D014443:Tyrosine / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018106:CD28 Antigens; D017252:CD3 Complex; C069847:CD66 antigens; D015815:Cell Adhesion Molecules; D014443:Tyrosine
references.citation: J Biol Chem. 2001 Jun 29;276(26):24331-40
references.pmid: 11306560
references.citation: Nat Rev Immunol. 2006 Jun;6(6):433-46
references.pmid: 16724098
references.citation: Toxicol Pathol. 2007 Jun;35(4):495-516
references.pmid: 17562483
references.citation: J Biol Chem. 1999 Jan 1;274(1):335-44
references.pmid: 9867848
references.citation: Curr Opin Cell Biol. 1997 Oct;9(5):616-26
references.pmid: 9330864
references.citation: Thromb Haemost. 2011 Mar;105(3):396-408
references.pmid: 21174005
references.citation: Exp Cell Res. 1999 Nov 1;252(2):243-9
references.pmid: 11501563
references.citation: Oncogene. 1997 Feb 20;14(7):783-90
references.pmid: 9047385
references.citation: Biochim Biophys Acta. 1986 Aug 21;860(2):236-42
references.pmid: 3488762
references.citation: Neth J Med. 2009 Jul-Aug;67(7):266-73
references.pmid: 19687520
references.citation: Anticancer Res. 1999 Jul-Aug;19(4C):3439-45
references.pmid: 10629632
references.citation: Nat Rev Rheumatol. 2010 Jan;6(1):21-9
references.pmid: 19949432
references.citation: Handb Exp Pharmacol. 2004;(165):283-341
references.pmid: 20455097
references.citation: Mol Cell. 2000 Feb;5(2):311-20
references.pmid: 10882072
references.citation: Blood. 2007 Dec 15;110(13):4223-33
references.pmid: 17761831
references.citation: Immunology. 2012 Jun;136(2):184-91
references.pmid: 22348442
references.citation: Blood. 2004 Nov 1;104(9):2761-6
references.pmid: 15242875
references.citation: J Biol Chem. 1998 Aug 28;273(35):22194-200
references.pmid: 9712832
references.citation: Int J Med Microbiol. 2008 Oct;298(7-8):553-60
references.pmid: 18606569
references.citation: Tumour Biol. 1988;9(2-3):63-83
references.pmid: 3041547
references.citation: Int J Biochem Cell Biol. 2012 Jan;44(1):11-5
references.pmid: 22024155
references.citation: Oncogene. 1995 Oct 19;11(8):1649-55
references.pmid: 7478590
references.citation: Eur J Immunol. 1998 Nov;28(11):3664-74
references.pmid: 9842909
references.citation: Immunity. 2010 Oct 29;33(4):620-31
references.pmid: 21029969
references.citation: J Leukoc Biol. 2003 Jul;74(1):126-34
references.pmid: 12832451
references.citation: Mol Cell Proteomics. 2012 Jul;11(7):M111.012914
references.pmid: 22457534
references.citation: J Biol Chem. 1985 Apr 10;260(7):4461-7
references.pmid: 3884611
references.citation: Cancer Res. 2000 Mar 1;60(5):1236-44
references.pmid: 10728682
references.citation: Trends Endocrinol Metab. 2002 Aug;13(6):240-5
references.pmid: 12128284
references.citation: J Cell Biol. 1985 Sep;101(3):942-8
references.pmid: 2993317
references.citation: Curr Opin Cell Biol. 2006 Oct;18(5):565-71
references.pmid: 16919437
references.citation: Exp Cell Res. 2000 Nov 25;261(1):19-24
references.pmid: 11082271
references.citation: Curr Oncol. 2009 May;16(3):46-9
references.pmid: 19526085
references.citation: J Cell Sci. 2010 May 15;123(Pt 10):1603-11
references.pmid: 20445011
references.citation: Nat Immunol. 2008 Nov;9(11):1270-8
references.pmid: 18836450
references.citation: Colloids Surf B Biointerfaces. 2011 Oct 1;87(1):146-50
references.pmid: 21640565
references.citation: J Clin Invest. 2004 Oct;114(7):944-52
references.pmid: 15467833
references.citation: Nat Rev Immunol. 2009 Aug;9(8):581-93
references.pmid: 19498381
references.citation: J Biol Chem. 2005 Jan 21;280(3):2361-9
references.pmid: 15536067
references.citation: Endothelium. 2003;10(6):319-28
references.pmid: 14741847
references.citation: Cell Mol Life Sci. 2011 Aug;68(16):2667-88
references.pmid: 21560073
references.citation: Eur J Cancer. 2003 Jan;39(2):184-91
references.pmid: 12509950
references.citation: J Immunol. 2002 May 15;168(10):5139-46
references.pmid: 11994468
references.citation: Leukemia. 2006 Sep;20(9):1487-95
references.pmid: 16791265
references.citation: Tumour Biol. 2000 Jan-Feb;21(1):11-20
references.pmid: 10601837
references.citation: Lung Cancer. 2008 Jun;60(3):309-12
references.pmid: 18462829
references.citation: Gastroenterology. 2005 Jun;128(7):1796-804
references.pmid: 15940614
references.citation: Genomics. 1992 Oct;14(2):384-90
references.pmid: 1427854